Skip to main content

Month: December 2022

Asensus Announces Senhance Program Initiation at Kashiwa Kosei General Hospital of Japan

Continued expansion of the Senhance Program in the region RESEARCH TRIANGLE PARK, N.C., Dec. 29, 2022 (GLOBE NEWSWIRE) — Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced that Kashiwa Kosei General Hospital in Kashiwa, Japan has entered into an agreement to lease and utilize a Senhance® Surgical System. “We are pleased to be partnering with another impressive institution as we continue to see high adoption rates in one of the fastest growing regions for Asensus,” said Anthony Fernando, Asensus Surgical President and CEO. “The recently approved thoracic indication will be a great addition to the Kashiwa Kosei General Hospital’s surgery department, and we look forward...

Continue reading

Kingsoft Cloud Announces Results of Extraordinary General Meeting Following Proposed Dual Primary Listing on Hong Kong Stock Exchange and New Board Appointment

BEIJING, Dec. 29, 2022 (GLOBE NEWSWIRE) — Kingsoft Cloud Holdings Limited (“we,” “Kingsoft Cloud” or the “Company”) (NASDAQ: KC), a leading independent cloud service provider in China, today announced that the shareholders of the Company duly adopted all the resolutions proposed by the Company at its extraordinary general meeting of shareholders held in Beijing today, with high approval rate, paving way to Company’s proposed listing on Main Board of The Stock Exchange of Hong Kong Limited. Earlier on December 23, 2022, the Company announced the proposed dual primary listing of its ordinary shares, par value US$0.001 per share by way of introduction on the Main Board of The Stock Exchange of Hong Kong Limited. Subject to final listing approval from the SEHK, the Shares are expected to commence trading on the Main Board of the SEHK...

Continue reading

Cleantech Building Materials: DEBT CONVERSION AND ISSUE OF NEW SHARES

29 December 2022 CLEANTECH BUILDING MATERIALS PLC, NASDAQ FIRST NORTH GROWTH MARKET, COPENHAGEN TICKER:  CBMISIN: GBOOBD1LVD21 CLEANTECH BUILDING MATERIALS PLC DEBT CONVERSION AND ISSUE OF NEW SHARES Cleantech Building Materials PLC (“CBM” or the “Company”) announces that following the signature of the subscription agreement in July 2019 with a family office (the “Investor”) (the “Agreement”) it has reached an agreement with the Investor to convert €300,000 of outstanding debt under the Agreement at €1.25 per share into 240,000 new ordinary shares of £0.10 nominal par value each in the Company (“Ordinary Shares”), and for the new Ordinary Shares to be issued to the Investor (the “Conversion”). Following the Conversion the Investor will not hold 5% or more of the Company’s issued share capital. The Company will apply for the 240,000 new...

Continue reading

Form 8.3 – [Form-8.3 EMIS GROUP PLC 28 12 2022] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree EMIS GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

Himax Unites with Seeed Studio to Bring SenseCAP LoRaWAN Vision AI Sensor on Smart Agriculture to CES 2023

TinyML AI Combined with LoRaWAN to Enable Ultralow Power, Long-Range Transmission and High-Performance AI for Indoor and Outdoor Utilization TAINAN, Taiwan and SHENZHEN, China , Dec. 29, 2022 (GLOBE NEWSWIRE) — Himax Technologies, Inc. (Nasdaq: HIMX) (“Himax” or “Company”), a leading supplier and fabless manufacturer of display drivers and other semiconductor products, and Seeed Studio, the IoT hardware partner providing services that empower developers to implement their projects and products for digital transformation, today announced the joint showcase of the SenseCAP A1101 LoRaWAN Vision AI Sensor, embedded with Himax WiseEye™ smart image sensing solution (“WiseEye”), at the upcoming CES 2023 from January 5 – 8, 2023 in Las Vegas, Nevada. Seeed Studio, with its tinyML Edge AI platform enabling expertise, has created...

Continue reading

RECHARGE RECEIVES DATASET AND REPORTS FROM AIRBORNE MAG SURVEY AT GEORGIA LAKE LITHIUM PROJECT TO DEMONSTRATE ‘STRUCTURAL CONTINUITY’ FROM NEIGHBOUR ROCK TECH AWAITING INTERPRETATION

Vancouver, BC, Dec. 29, 2022 (GLOBE NEWSWIRE) — Recharge Resources Ltd. (“Recharge” or the “Company”) (RR: CSE) (RECHF: OTC) (SL50: Frankfurt) is pleased to announce that Prospectair Geosurveys has finalized processing the high-resolution heliborne magnetic survey data collected from the company’s 100% owned Georgia Lake North and West Lithium Properties in Ontario, Canada (the “Property”). The Property is immediately contiguous to Rock Tech Lithium Inc’s (RCK–V) (“Rock Tech”) Georgia Lake Lithium Property and located approximately 160 km northeast of Thunder Bay, Ontario, within the Thunder Bay Mining Division. Recharge will be reviewing the data over the next month to implement a spring field program consisting of geological mapping and prospecting over target areas once conditions are favourable. CEO, David Greenway, stated,...

Continue reading

Standard Lithium Receives Notice of Allowance for Final U.S. Patent Covering DLE Process for Recovering Lithium From Brines

Successful Completion of USPTO Review Process for Company’s Lithium Extraction Patents VANCOUVER, British Columbia, Dec. 29, 2022 (GLOBE NEWSWIRE) — Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV: SLI) (NYSE American: SLI) (FRA: S5L), a leading near-commercial lithium company, is pleased to announce that the United States Patent and Trademark Office (“USPTO”) has issued a Notice of Allowance for Standard Lithium’s third U.S. patent application serial no. 16/895,783 titled “Process for Recovering Lithium from Brines”, This third U.S. patent application is in addition to Standard Lithium’s other two U.S. patent applications for which Notices of Allowance have been earlier issued by the USPTO (U.S. patent applications serial no.16/410,523 and serial no. 16/224/463, both also titled “Process for Recovering Lithium...

Continue reading

Junshi Biosciences Announces NEJM Publication of Results of Phase 3 Study of VV116 Versus PAXLOVID for Adults at High Risk for Progression to Severe COVID-19

SHANGHAI, China, Dec. 29, 2022 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, today announces the online publication in New England Journal (NEJM) of the Phase 3 trial (NCT05341609) comparing the efficacy and safety of VV116 (JT001) and nirmatrelvir/ritonavir (“PAXLOVID”) in the treatment of symptomatic patients with mild to moderate COVID-19 who are at high risk for progression to severe COVID-19 including death. It is the first time that NEJM published the clinical trial results of China-developed anti-SARS-CoV-2 drug. The study, led by Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, is the first “head-to-head” phase...

Continue reading

Minerva Surgical Announces Retirement of CEO David Clapper and Appointment of Todd Usen as Company President and CEO

SANTA CLARA, Calif., Dec. 28, 2022 (GLOBE NEWSWIRE) — Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical or the Company), a women’s health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today that David Clapper, who has served as President and Chief Executive Officer since 2011, has chosen to retire. The Company’s board of directors (the Board) has appointed industry executive Todd Usen as President and Chief Executive Officer of Minerva Surgical and a member of the Board to succeed Mr. Clapper effective January 2, 2023. To ensure a smooth leadership transition, Mr. Clapper will continue to serve in his role through Mr. Usen’s first day of employment and has entered into a consulting agreement for 12 months following his retirement. “On behalf of the Board, the management team, and Minerva...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.